No one has been doing the happy dance to the tune that Big Pharma has been singing the last couple of years. So now, it has decided to sing another tune.
We're done being on the defensive, goes the chorus of the new song, composed by Steve Ubl, president and CEO of the Pharmaceutical Researcher and Manufacturers Association (PharMA). Instead, we'll let our patients sing our praises.
That, at least, is the gist of the message Ubl and his messaging team have come up with. According to The Hill, Ubl thinks Washington decision makers should know the truth about costly drugs — that they save lives and control diseases that were deadly just a few years ago. So Ubl is going to send a battalion of researchers and patients to Congress to lobby on behalf of the very drugs lawmakers say are gouging the public and insurance providers.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.